Almac Wins Laboratory Team of the Year at The Irish Laboratory Awards 2013
News Dec 12, 2013
Almac’s Enzyme Research and Development team have been recognized at The Irish Laboratory Awards by winning “Laboratory Team of the Year.”
The awards, the first of their kind in Ireland, were held to recognize the success and achievements of Ireland’s internationally renowned scientists in areas including innovation, leadership and collaboration, and focus on the on-going work of Irish scientists to grow and develop sustainable, globally competitive science research.
The 30-strong Almac Biocatalysis Team has been at the forefront of innovation and solutions to a large number of Pharmaceutical companies and API manufacturers across the world.
Enzymatic technology is increasingly displacing chemical processes, yielding a higher quality product at a more attractive price while making significant benefit to the environment.
Tom Moody, Head of Biocatalysis and Isotope Chemistry at Almac commented, “Our team is recognized globally as a key player in the area of biocatalyst research and development and we are delighted to have won this award.”
“It is now acknowledged that the need for green, economic, robust and scalable processes is at the forefront of customer research plans for the synthesis of chiral APIs and intermediates. This award demonstrates our continued success in this field, and the Enzyme Research and Development team is a key to our future.”
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Anti-Malaria Drugs Delivered With CaffeineNews
Many drug delivery systems, such as capsules and tablets, can be difficult to swallow, especially for children. Making delivery systems out of polymer gels is an attractive option, but usually requires hazardous levels of heavy metals to be used. Now, scientists have found a way to build these gels from caffeine molecules.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018